Skip to main content
ANAPTYSBIO, INC logo

ANAPTYSBIO, INC — Investor Relations & Filings

Ticker · ANAB ISIN · US0327241065 LEI · 529900HH4WQT03IG1A12 US Professional, scientific and technical activities
Open in API
Filings indexed 636 across all filing types
Latest filing 2017-08-25 Director's Dealing
Country US United States of America
Listing US ANAB

About ANAPTYSBIO, INC

https://www.anaptysbio.com/

AnaptysBio, Inc. is a clinical-stage biotechnology company that focuses on the discovery and development of innovative immunology therapeutics. The company specializes in advancing immune cell-modulating antibodies designed to treat autoimmune and inflammatory diseases. Its therapeutic candidates target key pathways in the immune system to address significant unmet medical needs for various patient populations.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2017-08-25 English
FORM 3 SUBMISSION
Director's Dealing
2017-08-25 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The key content is the election of a new director, J. Anthony Ware, M.D., to the Board of Directors, including details about his term, independence, and compensation. This matches the description of announcements related to changes in the company's board of directors or senior management. The document is not a full annual report, audit report, or earnings release, nor is it a proxy solicitation or voting results announcement. It is specifically about a board/management change event. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 4381 characters, which is consistent with a typical 8-K filing for such an event. Confidence is high given the clear and explicit content about board appointment.
2017-08-24 English
FORM 4 SUBMISSION
Director's Dealing
2017-08-21 English
FORM 4 SUBMISSION
Director's Dealing
2017-08-16 English
10-Q
Interim / Quarterly Report Q2 2017
2017-08-10 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.